HK2 and cancer: Additionally, the correlation between aberrant HK2 expression and altered cell motility has been confirmed in many types of cancers, including pancreatic cancer [9], neuroblastoma [11], tongue squamous cell carcinoma [10], colon cancer [12], and breast cancer [13].